Novartis has pulled its TV ad for Lamisil from the air after receiving a letter from the FDA objecting to the sequence in which Novartis presents the qualifying and efficacy information for its anti-fungal.
Dual-Wavelength Laser Technology Demonstrates Promise in Atrophic Acne Scar Management
The Cutaneous Connection: Pearls for Atopic Dermatitis in College-Aged Patients
Discovering Dermatology Times: November 2023 Corticosteroid-Responsive Dermatoses Supplement
The Cutaneous Connection: Understanding Age-Approved Therapies in the Atopic Dermatitis Armamentarium
Greater Understanding Necessary in Treatment of Periorbital Facial Necrotizing Fasciitis, Review Argues
First Real-World Report of Near Complete Response With Cemiplimab in Penile Squamous Cell Carcinoma, Study Confirms